Spero Therapeutics (SPRO) Enterprise Value (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.40% |
| Dec 31, 2025 | 17.18% |
| Sep 30, 2025 | -55.85% |
| Jun 30, 2025 | 36.19% |
| Mar 31, 2025 | 7.57% |
| Dec 31, 2024 | 30.67% |
| Sep 30, 2024 | -20.09% |
| Jun 30, 2024 | 22.78% |
| Mar 31, 2024 | -7.78% |
| Dec 31, 2023 | 18.64% |
| Sep 30, 2023 | -20.77% |
| Jun 30, 2023 | 19.29% |
| Mar 31, 2023 | 11.78% |
| Dec 31, 2022 | -116.28% |
| Sep 30, 2022 | -11.11% |
| Jun 30, 2022 | 62.78% |
| Mar 31, 2022 | 16.69% |
| Dec 31, 2021 | -18.62% |
| Sep 30, 2021 | -24.39% |
| Jun 30, 2021 | 14.23% |
| Mar 31, 2021 | 8.85% |
| Dec 31, 2020 | 0.27% |
| Sep 30, 2020 | -78.31% |
| Jun 30, 2020 | 19.68% |
| Mar 31, 2020 | -8.28% |
| Dec 31, 2019 | 12.25% |
| Sep 30, 2019 | 9.27% |
| Jun 30, 2019 | 2.81% |
| Mar 31, 2019 | 7.86% |
| Dec 31, 2018 | 12.06% |
| Sep 30, 2018 | -97.44% |
| Jun 30, 2018 | 11.67% |
| Mar 31, 2018 | 13.68% |
| Dec 31, 2017 | -247.57% |
| Sep 30, 2017 | -490.81% |
| Dec 31, 2016 | -25.20% |